Also from this source


You just read:

Daiichi Sankyo to Present Findings From New Subgroup Analyses of Once-Daily SAVAYSA® (edoxaban) in NVAF and VTE at ACC's 65th Annual Scientific Session

News provided by

Daiichi Sankyo

24 Mar, 2016, 08:00 ET